The subsequent multivariate analysis (with 1087 patients actually included) validated that age, clinical stage and CYP24A1 expression were independent prognostic factors for overall survival of patients with breast cancer (Table 3). This evidence concerns the gene CYP24A1 and breast carcinoma.